Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

0.62
Delayed Data
As of 3:59pm ET
 +0.0217 / +3.63%
Today’s Change
0.55
Today|||52-Week Range
3.79
-57.24%
Year-to-Date
Biotech Stocks Under $5: 2 to Buy, 1 to Avoid
Sep 24 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close0.60
Today’s open0.59
Day’s range0.57 - 0.63
Volume3,885,545
Average volume (3 months)3,747,266
Market cap$286.0M
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+74.73%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CRBPCorbus Pharmaceutica...+0.27+4.14%
CRHMCRH Medical Corp-0.08-2.06%
FOMXFoamix Pharmaceutica...-0.25-2.63%
IDRAIdera Pharmaceutical...+0.25+10.82%
Data as of 4:02pm ET, 09/30/2016

Financials

Next reporting dateOctober 31, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts

Search for Jobs